Read + Share
Amedeo Smart
Independent Medical Education
King BH, Baumgartner JM, Kelly KJ, Marmor RA, et al. Preoperative bevacizumab does not increase complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. PLoS One 2020;15:e0243252.PMID: 33270763
Email
LinkedIn
Facebook
Twitter
Privacy Policy